Proteins are one of the primary components of the food, both in terms of nutrition and function. They are main source of amino acids, essential for synthesis of proteins, and also source of energy. Additionally, many proteins exhibit specifi c biological activities, which may have effect on functional or pro-health properties of food products. These proteins and their hydrolysis products, peptides, may infl uence the properties of food and human organism. The number of commercially available food products containing bioactive peptides is very low, apart from that milk proteins are their rich source. It could be supposed that number of available products with declared activity will rise in near future because of observed strong uptrend on interest in such products. Molecular and biological properties of milk proteins, as precursors of bioactive peptides was characterised in the work. Therefore, the strategy of research and obtaining of such peptides both in laboratory and industrial scale, as well as the range of their commercial application, was presented. Several examples of research efforts presenting high potential to develop new products containing bioactive peptides from milk proteins and predetermined as nutraceuticals was described.
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Research into bioactive peptides began in the 1950s. Initially, researchers and technology experts focused their attention on peptides that activate taste receptors. In 1978, Yamasaki and Maekawa [1978] isolated the "delicious peptide" from papain-hydrolysed beef which gives broth its characteristic "meaty" taste (umami/savory). The above authors relied on gel fi ltration, ion-exchange chromatography, fi lter paper electrophoresis and Edman degradation to determine the peptide's sequence: H-Lys-Gly-Asp-Glu-Glu-Ser--Leu-Ala-OH. They also demonstrated that selected fragments of that peptide taste umami, sour, salty, bitter or sweet. Therefore fragments of the analysed peptide delivered wide bouquet of taste sensations. Research into peptides expands our knowledge of the correlations between health and diet. Nutrition plays a key role in the prevention of various diseases, and it optimizes health and well-being [Mils et al. 2011 ].
Those observations contributed to the emergence of functional foods -products that provide health benefi ts in addition to basic nutrition. The functional food market abounds in dairy products, including fermented milk products containing lactic acid bacteria which have probiotic properties [Fuller 1989 ] and produce secondary metabolites that deliver health benefi ts [Stanton et al. 2005] . Milk is a rich source of bioactive substances with benefi cial effects for humans [Expósito and Recio 2006 , Korhonen and Pihlanto 2006 , Mils et al. 2011 , Phelan et al. 2009 ]. Milk protein derivatives are physiologically active peptides which are released in the digestive tract [Chabance et al. 1998 , Ferranti et al. 2004 , Meisel and Frister 1989 , Parrot et al. 2003 , Svedberg et al. 1985 . β-casomorphins and casein phosphopeptides (CPP) are produced in vivo after the consumption of dairy products, including milk, fermented milk, cheese and yogurt [Chabance et al. 1998 , Hernández-Ledesma et al. 2004 , Kasai et al. 1992 , Meisel and Frister 1989 , Parrot et al. 2003 , Svedberg et al. 1985 . Food proteins and peptides are hydrolysed at different stages: ingestion, digestion and absorption [Shimizu 2004 , Vermeirssen et al. 2004 . The exact amount of a peptide that can be released and activated during the consumption of a balanced diet remains unknown because proteolytic enzymes are characterised by varied specifi city, therefore, the range of bioactive fragments released from a precursor protein cannot be accurately predicted [Dziuba and Darewicz 2007 , Dziuba et al. 2006 , Phelan et al. 2009 ]. The presence of bioactive peptides in dairy products such as cheese, fermented milk and yoghurt has been reported in numerous research studies [FitzGerald et al. 2004 , Gagnaire 2001 , Gobbetti et al. 2002 , Korhonen and Pihlanto 2006 , Meisel et al. 1997 , Nakamura et al. 1995 , Saito et al. 2000 .
The choice of commercially available foods containing bioactive peptides, derivatives of milk proteins and other proteins, is limited. Bioactive peptides are a rapidly developing fi eld of research which should signifi cantly contribute to the availability of functional foods on the market in the near future. The molecular and biological properties of milk proteins as precursors of bioactive peptides have been described in this study. The protocols for synthesizing and analysing bioactive peptides in a laboratory and in industrial applications have been discussed. Research studies suggesting that bioactive peptides from milk proteins can be used in the production of nutraceuticals have been overviewed.
FOOD PRODUCTS AS A COMPLEX MOLECULAR SYSTEM
New methods supporting the isolation and identifi cation of chemical compounds in food ingredients and products, including proteins and peptides, are being constantly developed. In the process of designing high-quality products, food technologists analyse the correlations between the product's quality and its molecular structure, defi ned as a molecular system with a specifi c, hierarchical molecular composition and molecular interactions. The structural and functional hierarchy of chemical compounds found in food ingredients and products accounts for their increasing molecular complexity , Eads 1994 . Interactions that shape the structure and properties, including functional properties, of foods and ingredients are observed at every level of their organisational structure. The molecular structure of chemical compounds in foods is described by a chemical formula (which is often limited to the number and type of atoms), confi guration (arrangement of atoms in a monomer), sequence (sequence of monomer residues in polymers), conformation (rotation angles between bonds), secondary, tertiary and quarternary structure, energy levels of electrons, mobility (distribution of energy between translational, rotational and vibrational degrees of freedom), range and type of molecular interactions (geometry, intermolecular forces) and selected macromolecule fragments with different functions (functional motifs and domains). Many domains have a unique spatial structure and, subject to context, they can be regarded as functional, as well as structural elements. As molecular systems, food ingredients and products contain structures that differ in size by 15 orders of magnitude -from subatomic particles (the diameter of the atomic nucleus is approximately 10 -15 m) to macroscopic structures (muscles can have the length of 1 m). The time (duration) of molecular-level processes during which functional properties are shaped can differ by 22 orders of magnitude -from femtoseconds (photon absorption time) to a year (sugar crystallization).
The strength of internal and external (applied) forces at different structural levels of a food product, a dynamic and multiphase system, can also differ by more than 10 orders of magnitude. A sound knowledge of the structure and functions of chemical compounds is required in the process of designing functional foods. The interactions between different ingredients have to be taken into account in structural and functional analyses.
NOMENCLATURE AND MOLECULAR PROPERTIES OF MILK PROTEINS
In the living world, various protein systems are synthesized through the formation of monomer subunit associations. Those associations have a fi xed structure, and they comprise several identical or different subunits or many identical subunits. Casein and whey proteins make up the protein system of milk. Whey protein molecules have a globular structure with a relatively high content of helical structures and a balanced distribution of acidic and basic amino acid residues and hydrophobic and hydrophilic amino acid residues along the polypeptide chain [Madureira et al. 2007 ]. In comparison with standard globular proteins such as whey proteins, casein is characterised by a unique, amphiphilic structure [Swaisgood 1992 ]. This characteristic feature can be observed in the structure of monomeric subunits of the major forms of casein which contain fragments of hydrophilic and hydrophobic protein molecules. Milk casein comprises large, porous and spherical particles which are known as casein micelles. Casein micelles differ from other protein systems for various reasons. Firstly, despite their large size and fi xed structure, casein micelles are characterised by signifi cant variability. The smallest micelles with the diameter of around 25 nm comprise approximately 450 monomeric subunits, whereas the largest micelles with a diameter greater than 150 nm can contain more than 10,000 monomeric subunits [Waugh 1971 ]. Secondly, even such a high number of monomeric subunits aggregates in an orderly fashion to create micelles from non-identical monomeric subunits of the four major forms of casein: α s1 , α s2 , β and κ [Dziuba 1986 ]. The properties of micellar casein and whey proteins largely determine the behavior of milk during technological processes such as pasteurization, sterilization, condensation and cheese curd formation. Those properties can be attributed to the specifi c structure of milk proteins and structural changes that take place during processing. A sound knowledge of the structure of milk proteins and structural changes induced by processing is required for designing new production technologies and analysing dairy products.
Milk proteins have been defi ned and classifi ed by the American Dairy Science Association Committee on the Nomenclature, Classifi cation, and Methodology of Milk Proteins [Farrell et al. 2004] . The relevant information is continuously updated. Casein is defi ned as a phosphoprotein which is precipitated at the temperature of 20°C from raw skimmed milk acidifi ed to the pH of 4.6. Based on the results of electrophoretic separation and evaluations of amino acid sequence homology in different casein fractions, four major families of casein have been identifi ed: α s1 , α s2 , β and κ.
The α s1 -casein family, which makes up to 40% of all casein fractions in bovine milk, contains one primary component and one secondary component (in smaller quantities). Both proteins are built of single polypeptide chains with the same amino acid sequence but different degrees of phosphorylation [Eigel et al. 2006 , Mercie et al. 1971 . The secondary component contains the ninth additional phosphoserine residue. The reference protein for the α s1 -casein family is α s1 -casein, genetic variant B-8P whose polypeptide chain contains 199 amino acid residues. Seven genetic variants of this casein have been identifi ed to date: A, B, C, D, E, F, G and H [Farrell et al. 2004 , Grosclaude and Ribadeau-Dumas 1973 , Mercie et al. 1971 . The differences between the above genetic variants and the genetic variants of the remaining casein families result from the deletion or genetically controlled substitution of amino acids. The degree of association of α s1 -casein fractions is determined by ionic strength (salt concentrations in a solution): tetrameters are formed in solutions with salt concentrations below 0.1 M, octamers -in solutions with salt concentrations of 0.1 to 0.4, whereas in solutions with salt concentrations higher than 0.5 M, α s1 -casein becomes insoluble (is salted out).
The α s2 -casein family is more complex. It accounts for up to 10% of all casein fractions in bovine milk, and it is represented by two primary components www.food.actapol.net/ and several secondary components. The reference protein for the α s2 -casein family is α s2 -casein, genetic variant A-11P whose polypeptide chain contains 207 amino acid residues and a single intramolecular disulfi de bond [Swaisgood 1992 ]. Four genetic variants of α s2 -casein have been identifi ed to date: A, B, C and D , Grosclaude 1979 , Mahè and Grosclaude 1982 . Fractions of α s2 --casein are more sensitive to Ca 2+ concentrations than α s1 -casein fractions, and they are precipitated in the presence of 2 mM Ca 2+ [Farrell et al. 2004 ] . The β-casein family, which makes up to 45% of all casein fractions in bovine milk, combines many fractions, including the products of partial hydrolysis of the major β-casein fraction by milk plasmin [Farrell et al. 2004] . This process gives rise to γ 1 , γ 2 and γ 3 -casein fractions which constitute fragments 29--209, 106-209 and 108-209 [Dong and Ng-Kwai-Hang 1998 , Han et al. 2000 , Swaisgood 1982 , Visser et al. 1995 , Waugh 1971 . In isolated systems, β-casein aggregates to form "micelles" with association number 20 (fi ve connected tetramers) at room temperature [Kumosinski et al. 1993] .
The κ-casein family contains one major sugar-free component and at least six secondary components. Secondary components are characterised by different degrees of phosphorylation (0 or 1 phosphate residue) and glycosylation [Farrell et al. 2004] . κ-casein accounts for up to 15% of all casein fractions in bovine milk. The reference protein for this casein family is κ-casein, genetic variant A-1P whose polypeptide chain contains 169 amino acid residues and one phosphate residue. Eleven genetic variants of κ-casein have been identifi ed to date: A, B, C, E, F 1 , F 2 , G 1 , G 2 , H, I and J [Alexander et al. 1988 , Grosclaude et al. 1972 , Mercier 1973 . κ-casein contains up to one phosphate residue, and it is soluble in the presence of calcium ions. κ-casein molecules can associate with the molecules of α s1 , α s2 and β casein, and they protect them against precipitation in the presence of calcium ions, which leads to the formation of stable colloidal molecules of micellar casein [Horne 2006 ]. Isolated κ-casein polymerizes to form a mixture of dimers to octamers.
Whey proteins are milk proteins which remain in whey after the precipitation of casein. Whey proteins account for around 20% of all milk proteins [Madureira et al. 2007 ]. The predominant whey proteins are β-lactoglobulin (β-Lg) and α-lactalbumin (α-La). Other whey proteins include bovine serum albumin (BSA), immunoglobulins (IG), lactoferrin (BLF), lactoperoxidase (LP) and other.
β-lactoglobulin is a major whey protein with 11 identifi ed genetic variants: A, B, C, D, E, F, G, H, I, J, W [Brignon et al. 1977 , Conti et al. 1988 , Godovac-Zimmermann et al. 1996 , 1990 , Jakob and Puhan 1992 . Variants A and B are most commonly encountered [Jakob and Puhan 1992] . The reference protein for the β-lactoglobulin family is β-lactoglobulin, genetic variant B whose polypeptide chain contains 162 amino acid residues [Eigel et al. 1984] . β-lactoglobulin occurs as a stable dimer at the pH of 5.2 to 7.0, as a monomer at the pH of 3.0 and above 8.0, and as an octamer at the pH of 3.5 to 5.2 [Madureira et al. 2007] .
Similarly to β-lactoglobulin, α-lactalbumin is produced in the mammary gland. α-lactalbumin participates in the biosynthesis of lactose, and it is an allosteric effector of β-1,4-galactosyltransferase [Kuhn et al. 1980] . Three genetic variants of α-lactalbumin have been identifi ed: A, B and C [Madureira et al. 2007 ]. Variant B is a reference protein whose polypeptide chain contains 123 amino acid residues. The globular structure of α-lactalbumin is stabilised by disulfi de bonds at the pH of 5.4 to 9.0 [Permyakov and Berliner 2000] .
Bovine serum albumin is not synthesized in the mammary gland, but it is transferred from blood to milk. A single BSA polypeptide chain contains 582 amino acid residues [Carter and Ho 1994] .
Immunoglobulins are protein complexes synthesized by B lymphocytes. They are responsible for immunological functions [Madureira et al. 2007] . aspects. Acta Sci. Pol., Technol. Aliment. 13(1), 5-25.
www.food.actapol.net/ The remaining whey proteins account for around 0.6% of total milk proteins and show various types of biological activity.
The therapeutic properties of milk proteins have been investigated by many researchers in the past decades [Madureira et al. 2007 , Mils et al. 2011 , Zimecki and Kruzel 2007 . Whey proteins contain lactoferrin, β-lactoglobulin, α-lactalbumin and serum albumin, and they were found to inhibit the growth of tumors more effectively than other food proteins [Parodi 2007] . In an acidic environment, α-lactalbumin forms the HAMLET (human α-lactalbumin made lethal to tumor cells) complex with oleic acid which inhibits the proliferation of various tumors by an apoptosislike mechanism [Svanborg et al. 2003 ]. The BAM-LET complex, the bovine equivalent of HAMLET, has been recently found to exert a strong cytotoxic effect on eight lines of tumor cells by increasing the permeability of the lysosomal membrane [Rammer et al. 2010] .
Proteomic research into MFGM (milk fat globule membrane) proteins has been developing rapidly in recent years [Cavaletto et al. 2008 , Manso et al. 2005 , Reinhardt and Lippolis 2008 . A fatty-acid-bindingprotein isolated from MFGM has been found to inhibit the growth of breast tumor cells [Spitsberg 2005 ].
MILK PROTEINS AS BIOACTIVE PEPTIDE PRECURSORS COMPLEMENTING THE SYSTEM OF ENDOGENOUS BIOACTIVE PEPTIDES
Research carried out by numerous scientifi c centers around the world led to the identifi cation and description of a vast number of biologically active peptides isolated from tissues and fl uids of different organisms, including bacteria, fungi, plants and animals. Those peptides are characterised by signifi cant chemical diversity. The discussed group of compounds contains simple dipeptides as well as complex, linear and cyclic oligopeptides and polypeptides which are often modifi ed by posttranslational glycosylation, phosphorylation, acylation or hydroxylation of amino acid residues [Dziuba 2005 , Dziuba et al. 1999 . The precursors of many biological active peptides include food proteins. Food protein peptides can lower blood pressure, inhibit the activity of proline-specifi c endopeptidases, stimulate the immune system, act as opioids and opioid antagonists, contract smooth muscles, inhibit blood platelet aggregation, inhibit HIV proteinase and oxidation processes, demonstrate antibacterial and fungicidal activity and surface activity, bind ions, participate in mineral transport, determine sensory properties, improve the nutritional value of foods and control body weight [Dziuba and Darewicz 2007] . According to the current state of scientifi c knowledge, in addition to fulfi lling its basic roles, every protein can contain fragments that control life processes in various organisms [Karelin et al. 1998 ]. New, additional criteria have been developed for evaluating proteins as a potential source of biologically active peptides. Those criteria and the protocols for investigating proteins as precursors of bioactive peptides have been discussed in detail in our previous studies [Dziuba et al. 2012, Dziuba and , and the relevant information is available in the BIOPEP [Dziuba et al. 2003 ] online database of proteins and bioactive peptides (http://www.uwm.edu. pl/biochemia). Potentially biologically active protein fragments with structural motifs corresponding to bioactive peptides remain inactive in precursor protein sequences. When released from the precursor by proteolytic enzymes during technological processing or digestion, those fragments are ingested and absorbed, and they can interact with the corresponding receptors and affect the body's physiological functions. They can thus complement the system of endogenous bioactive peptides. This process is illustrated in the diagram in Figure 1 .
Many physiologically active peptides are multifunctional. They play regulatory roles, but also directly infl uence various developmental and metabolic processes. It should be noted that specifi c physiological effects are not always manifested when a peptide is administered orally or when it is released by digestive tract enzymes. Peptides, for example milk protein peptides, which play different physiological roles, including opioids and immunostimulants, probably undergo further hydrolysis in the body , Phelan et al. 2009 ].
PROFILES OF POTENTIAL BIOLOGICAL ACTIVITY OF MILK PROTEINS
Every protein sequence can be described based on its profi le of potential biological activity and the frequency of motifs representing a given type of potential activity . The profi le of potential biological activity describes the type, number and location of active fragments. The frequency of a bioactive fragment occurrence in the protein sequence is a quantitative measure calculated as the ratio of the number of active fragments to the total number of amino acid residues. Milk proteins are generally a very rich source of bioactive peptides. Major milk proteins as precursors of bioactive peptides are characterised in Table 1 based on BIOPEP data. The differences between genetic variants of milk proteins do not signifi cantly affect their ability to act as precursors of biologically active peptides. Fragments of casein polypeptide chain sequences containing phosphoserine residues participate in the transport and absorption of Ca +2 ions. The following major categories of bioactive peptides have been derived from milk proteins: antihypertensive, antithrombotic, opioid, casein phosphopeptides, antimicrobial, cytomodulatory, immunomodulatory and other , Korhonen and Pihlanto 2006 , Mils et al. 2011 , Phelan et al. 2009 , Stuknyte et al. 2011 . 
STRATEGY FOR ISOLATING AND ANALYSING BIOACTIVE PEPTIDES
Scientifi c advancements expand our knowledge, including the knowledge of food. Continuously improved research methods enable scientists to probe deeper into the nature of matter and natural phenomena. Fundamental barriers between traditional biological sciences are gradually eliminated as research becomes increasingly interdisciplinary. Biochemistry, molecular biology, genetics, immunology, microbiology, food science, physiology, pharmacology and molecular medicine speak the same language and apply the same molecular tools and methods. Despite the above, our ability to answer scientifi c questions is limited by the current state of knowledge and the possibilities offered by the available methods of scientifi c inquiry. Various theoretical and experimental methods are used to explain phenomena at different molecular levels. In proteomic and peptidomic research, analytical techniques are combined with computer-aided methods [Carrasco-Castilla et al. 2012] as part of an emerging scientifi c discipline -bioinformatics. According to the Oxford English Dictionary, bioinformatics is the science of collecting and analysing biological data. The rapid development of computer technology, IT and statistical methods contributed to the development of an extensive system of biological databases and servers [Dziuba et al. 1999 , Minkiewicz et al. 2008 . In addition to information about the collected biological compounds, those databases contain tools for comprehensive data analysis. The BIOPEP database offers such solutions. The strategy for analysing proteins and bioactive peptides is shown in Figure 2 [ ]. In the presented solution, computer technology is combined with analytical methods. The results can be used in food research, and they can support the development of new technologies for the production of special purpose foods. The main stages of research into bioactive peptides and precursor proteins include the identifi cation and selection of proteins characterised by the highest frequency of motifs with the given activity [Dziuba and Darewicz 2007] , selection of enzymes that release those motifs (in silico proteolysis) [Dziuba et al. 2006] , verifi cation of the results of in silico proteolysis by analytical methods [Vecruysse et al. 2009 ], peptides isolation and purifi cation [Korhonen and Pihlanto 2006] application of in vitro methods, followed by ex vivo and in vivo methods in evaluations of biological activity [Expósito and Recio 2006, Simos et al. 2011] , and determination of correlations between structure and function [Iwaniak 2011 ]. The combination of bioinformatics and chemometrics tools speeds up the screening of various peptide sources with high levels of biological activity and optimises the process of isolating (selected substrates) and identifying peptides in food products. The process of identifying and isolating peptides in a laboratory and in industrial applications is overviewed in Table 2 [Carrasco-Castilla et al. , Korhonen and Pihlanto 2006 , 2007 , Langevin et al. 2012 , Minkiewicz and Dziuba 2009 .
As a precursor of bioactive peptides, every protein has to undergo proteolysis. Bioactive peptides can be released by enzymes from food precursor proteins during processing (ripening, fermentation, heating), storage and in vitro proteolysis [Korhonen and Pihlanto 2006 , Sanlidere Algolu and Őner 2011 , Tavares et al. 2011 ]. Bioactive fragments released in the presence of proteolytic enzymes can constitute an ingredient of a food product or can be isolated by advanced industrial separation methods [Korhonen and Pihlanto 2007] . Bioactive peptides can also be produced by chemical (in an almost non-aqueous phase) and enzymatic synthesis, and with the use of recombinant DNA methods [Minkiewicz and Dziuba 2009] . Synthesis is the most popular method of obtaining bioactive peptides in a laboratory [Narai-Kanayama et al. 2010] . In industrial applications, foods containing bioactive peptides are produced by hydrolysis with the involvement of digestive proteolytic enzymes and proteolytic enzymes of microbiological origin [Korhonen and Pihlanto 2006] . Pepsin and trypsin are commonly applied in enzymatic hydrolysis of proteins. They are generally used to produce ACE inhibitory peptides, namely antihypertensive peptides and calcium-binding phosphopeptides [Adt et al. 2011 , FitzGerald et al. 2004 . Other digestive enzymes and combinations of various proteinases, including alcalase, chymotrypsin, pancreatin Information adapted from references: Carrasco-Castilla et al. [2012] , Pihlanto [2006, 2007] , Langevin et al. [2012] , Minkiewicz and Dziuba [2009] . aspects. Acta Sci. Pol., Technol. Aliment. 13(1), 5-25.
www.food.actapol.net/ and thermolysin, as well as enzymes of microbiological origin are also used to produce bioactive peptides from various proteins [Kilara and Panayam 2003, Korhonen and Pihlanto 2003 ]. Many microorganisms found in dairy starter cultures are highly proteolytic. Their proteolytic systems consist of cell wall-bound proteinases and numerous intracellular proteinases, among them endopeptidases, aminopeptidases, tripeptidases and dipeptidases [Christensen et al. 1999] . Examples of bioactive peptides released by microbiological enzymes from milk proteins are shown in Table 3 [ Pihlanto 2006, Nielsen et al. 2009 ].
The majority of bioactive peptides released from proteins and found in processed foods are characterised by antihypertensive, antioxidant, antimicrobial, immunomodulatory and mineral binding activity. Carrasco-Castilla et al. [2012] discussed various methods for evaluating the fi ve types of activity of peptides released by protein hydrolysis. IPP and VPP peptides are generally described and analysed as inhibitors of the angiotensin I-converting enzyme, one of the key factors controlling blood pressure [Panchaud et al. 2012] . Their inhibitory capacity is determined by spectrophotometry combined with HPLC, and fl uorimetric methods are also applied. The antihypertensive effects of food products containing peptides have been studied in vivo in rats. The antioxidant properties of peptides have been researched extensively during in vitro chemical and biological studies [Antolovich et al. 2002] , in vivo experiments on animals and clinical trials involving biomarkers [Karadag et al. 2009 ]. Antimicrobial peptides and foods containing such peptides may be used as antibacterial, antiviral and antifungal agents. Their effi cacy is determined by identifying α s1 -casein Arg-Pro-Lys-His-Pro-Ile-Lys-His-Gln ACE inhibitor www.food.actapol.net/ minimum concentrations that inhibit the proliferation of a given group of microorganisms [Najafi an and Babji 2012] . Phosphopeptides, which are casein derivatives, can form soluble salts, organic phosphate derivatives, which participate in the transport and absorption of divalent cations, in particular calcium. The above processes play an important role in bone tissue reconstruction and prevention of dental diseases [Adt et al. 2011] . Ability of peptides to bind minerals is determined by conductometric titration of free calcium and spectrophotometric methods [Hansen et al. 1997] . Assays aiming to determine the immunomodulatory properties of peptides have to account for a variety of factors (susceptibility to digestion in the gastrointestinal tract, peptides' effect on the mucosal immune system, toxicity), therefore, they often deliver controversial results. Most studies investigating the immunomodulatory properties of peptides evaluate their infl uence on lymphocyte activity and proliferation, cytokinin secretion and the production of antibodies [Durrieu et al. 2006 , Stuknyte et al. 2011 .
COMMERCIALLY AVAILABLE FOODS AND INTERMEDIATE PRODUCTS CONTAINING BIOACTIVE PEPTIDES DERIVED FROM MILK PROTEINS
Signifi cant progress has been made in laboratory research investigating bioactive peptides in protein hydrolysates [Carrasco-Castilla et al. 2012] . Conventional and unconventional sources of peptides from protein hydrolysates have been identifi ed, the functions (functional peptides) and physiological significance of peptides have been described. Foods containing bioactive peptides from protein hydrolysis have been approved for mass consumption by health authorities, nevertheless, their availability on the market continues to be limited. Researchers show a growing interest in bioactive peptides, which could imply that the choice of functional foods on the consumer market will grow steadily in the near future. Bioactive peptides are already used in the production of functional foods, including nutraceuticals [Mils et al. 2011 , Phelan et al. 2009 ]. [Hata et al. 1996 , Mizushima et al. 2004 , Sepio et al. 2003 ]. Those products are classifi ed as functional foods. They contain peptides IPP, VPP and LKPNM which have been thoroughly researched and claimed as safe for consumption. Although peptides carry a great potential as food supplements, they cannot always be included in food products. In some cases, additional safety information may be required regarding the potential toxicity, cytotoxicity and allergenicity of bioactive peptides [Phelan et al. 2009] . Maeno et al. [2005] found that casein-derived products and Val-Pro-Pro peptides from fermented milk powder did not exhibit toxic activity. The above authors argued that there is no need to determine LOEL (lowest observed effect level) or MTD (maximally tolerated dose) doses of the analysed products which were set at more than 2 g per kg -1 BW per day -1 in a 28-day study of rats. They concluded that in experiments of the type, MTD and NOEL (no observed effect level) doses for casein hydrolysate powder administered once daily for 13 weeks exceeded 1 g per kg -1 BW per day -1 and for Val-Pro-Pro and Ile-ProPro -more than 6 mg per kg -1 BW per day -1 [Mizuno et al. 2005] . To date, Val-Pro-Pro and Ile-Pro-Pro have not been found to exert toxic effects. The cited authors also demonstrated that fermented milk containing ValPro-Pro and Ile-Pro-Pro casein-derived tripeptides did not affect the reproductive ability of rats (NOAEL, no observed adverse effect level). The NOAEL dose for fermented milk in reference to the reproductive parameters of female and male rats exceeded 2 g per kg -1 BW -1 per day -1 , which is equivalent to 3.3 mg of Val-Pro-Pro and Ile-Pro-Pro per kg -1 BW -1 per day -1 . Similar NOAEL values were reported by Dent et al. [2007] in a study of rabbits and rats administered lactotripeptide in the prenatal or postnatal period. . The content of Val-Pro-Pro and Ile-Pro-Pro was determined at 2 -224 mg and 0.8 -95 mg, respectively, in hard cheese, 1 -120 mg and 1.5 -65 mg, respectively, in semi-hard cheese, and 0.4 -11 mg and 0 -11 mg, respectively, in soft cheese. The authors carried out an in vitro study and concluded that IC 50 values determined in vitro cannot be regarded as specifi c markers for describing the potential activity of the ACE inhibitor in various types of cheese in vivo. Clinical tests are needed to establish ACE inhibitor's antihypertensive properties.
Ortiz-Chao et al. [2009] hydrolysed β-lactoglobulin (β-Lg) with N Amano protease (enzyme produced by B. subtilis) to obtain the Ser-Ala-Pro-Leu-Arg-Val-Tyr heptapeptide whose sequence corresponds to fr. 36-42 β-Lg. ACE's inhibitory activity, expressed by the value of IC 50 , was determined at 8 mM, and it was higher than in any of the identifi ed inhibitors with β-Lg precursors. The activity of Ala-Leu-Pro-Met-His-Ile-Arg (fr. 142-148) and Leu-Gln-Lys-Trp (fr. 74-77) peptides, expressed by IC 50 , was determined at 42.6 and 34.7 mM, respectively. An in vitro study demonstrated that heptapeptides (fr. 142-148) can be hydrolysed by chymotrypsin during digestion [Roufi k et al. 2006] . Otte et al. [2011] analysed peptide profi les of fermented milk products containing Lactobacillus helveticus and Lacctococcus lactis strains. They determined the presence of peptides, ACE inhibitors derived mainly from β-casein and, in smaller quantities, from a s1 -and κ-casein. Fermentation temperature (Lc. lactis -27, 30 and 33°C, optimal temperature of approximately 30°C; Lb. helveticus -33, 37 and 40°C, optimal temperature above 40°C) signifi cantly infl uenced bacterial proliferation, the extent of lysis and ACE's inhibitory activity. Moslehishad et al. [2013] studied ACE inhibitory and antioxidant peptides in bovine and camel milk fermented with the use of Lactobacillus rhamnosus PTCC 1637 bacteria. Peptides released from camel milk proteins were characterised by higher ACE inhibitory activity and antioxidant activity than those derived from bovine milk proteins. The above can be attributed to a higher content of proline residues in camel milk proteins.
Uenishi et al. [2012] isolated the Leu-Pro-Gln--Asn-Ile-Pro-ProLeu (fr. β-casein 70-77) octapeptide with the ability to inhibit dipeptidyl peptidase-4 (DPP) (IC 50 ≤ 200 μM) from gouda cheese. DPP 4 inhibitors play an important role in controlling insulin levels, and they contribute to glucose tolerance in type 2 diabetes. The discussed protocol was used in many research studies of animals [Reimer et al. 2002 , Sudre et al. 2002 , Yasuda et al. 2004 and humans [Ahrén et al. 2004] . In a study of rats, an octapeptide isolated from gouda cheese was administered orally at 30 mg/100 g BW to demonstrate its benefi cial effect on glucose tolerance. The inhibitory potential of the analysed peptide was 100-times lower in comparison with commercially available preparations. Martinez et al. [2010] studied the gelation of a mixture of casein macropeptide (CMP), a C-terminal fragment of κ-casein containing 64 amino acids which is released by chymosin or pepsin, with β-lactoglobulin. They observed that synergistic interactions between CMP and β-Lg in aqueous solutions with the pH of 3.5-7 promote intensive gelation. Their fi ndings can be used in the production of molecular foods and food products containing CMP as a bioactive ingredient. The biological activity of CMP has been reviewed extensively by Thomä-Worringer et al. [2006] . CMP binds cholera enterotoxins and Escherichia coli, it inhibits bacterial and viral adhesion, demonstrates immunomodulatory activity, supports the proliferation of bifi dobacteria, inhibits gastric juice secretion and regulates blood fl ow.
CONCLUSIONS
Milk is a rich source of biologically active compounds which can be used in the production of functional foods. Contemporary consumers have a growing interest in foods which are not only a source of basic nutrition, but which also delay and alleviate the consequences of lifestyle diseases. A sound knowledge of the biological properties of milk compounds is needed to design such food. It should be noted, however, that the physiological activity of many bioactive milk components has been analysed mostly in in vitro studies and experiments conducted on animals, but never on humans. The development of economically feasible industrial methods for the production of bioactive milk components poses a new challenge for food scientists and food technology experts. Although the potential of milk proteins and peptides for the formulation of functional foods has been long demonstrated, they are still not mass produced. New research efforts are undertaken to optimize the activity of milk proteins and peptides in nutrition and their availability in the human body.
The choice of foods containing biologically active peptides continues to be limited. Newly identifi ed peptides will be introduced to the food processing industry with the advent of new technologies, such as membrane separation, nanofi ltration and ultrafi ltration. Macroencapsulation and nanoencapsulation methods supply new solutions that improve peptide stability in foods and during digestion.
Future research should focus on the content and biological availability of peptides, milk protein derivatives, in food. Further studies with application of proteomic, peptidomic and metabolomic method are required to investigate the physiological mechanisms responsible for the biological activity of peptides. The process of enriching foods with peptides can also give rise to legal concerns when health claims are made on the resulting end products.
